The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition - PubMed (original) (raw)
Review
. 2007 May 14;26(22):3227-39.
doi: 10.1038/sj.onc.1210414.
Affiliations
- PMID: 17496918
- DOI: 10.1038/sj.onc.1210414
Review
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
S Meloche et al. Oncogene. 2007.
Abstract
The Ras-dependent extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein (MAP) kinase pathway plays a central role in cell proliferation control. In normal cells, sustained activation of ERK1/ERK2 is necessary for G1- to S-phase progression and is associated with induction of positive regulators of the cell cycle and inactivation of antiproliferative genes. In cells expressing activated Ras or Raf mutants, hyperactivation of the ERK1/2 pathway elicits cell cycle arrest by inducing the accumulation of cyclin-dependent kinase inhibitors. In this review, we discuss the mechanisms by which activated ERK1/ERK2 regulate growth and cell cycle progression of mammalian somatic cells. We also highlight the findings obtained from gene disruption studies.
Similar articles
- Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M, Kasprzycka M, Liu X, Raghunath PN, Wlodarski P, Wasik MA. Marzec M, et al. Oncogene. 2007 Feb 8;26(6):813-21. doi: 10.1038/sj.onc.1209843. Epub 2006 Aug 7. Oncogene. 2007. PMID: 16909118 - Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
Yang W, Chen Y, Zhang Y, Wang X, Yang N, Zhu D. Yang W, et al. Cancer Res. 2006 Feb 1;66(3):1320-6. doi: 10.1158/0008-5472.CAN-05-3060. Cancer Res. 2006. PMID: 16452185 - Integrating the MAP kinase signal into the G1 phase cell cycle machinery.
Roovers K, Assoian RK. Roovers K, et al. Bioessays. 2000 Sep;22(9):818-26. doi: 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6. Bioessays. 2000. PMID: 10944584 Review. - ERK1/2 MAP kinases in cell survival and apoptosis.
Lu Z, Xu S. Lu Z, et al. IUBMB Life. 2006 Nov;58(11):621-31. doi: 10.1080/15216540600957438. IUBMB Life. 2006. PMID: 17085381 Review.
Cited by
- Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.
Saxena R, Chandra V, Manohar M, Hajela K, Debnath U, Prabhakar YS, Saini KS, Konwar R, Kumar S, Megu K, Roy BG, Dwivedi A. Saxena R, et al. PLoS One. 2013 Jun 19;8(6):e66246. doi: 10.1371/journal.pone.0066246. Print 2013. PLoS One. 2013. PMID: 23840429 Free PMC article. Retracted. - ERK1/2 in immune signalling.
Lucas RM, Luo L, Stow JL. Lucas RM, et al. Biochem Soc Trans. 2022 Oct 31;50(5):1341-1352. doi: 10.1042/BST20220271. Biochem Soc Trans. 2022. PMID: 36281999 Free PMC article. Review. - ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
Levidou G, Saetta AA, Gigelou F, Karlou M, Papanastasiou P, Stamatelli A, Kavantzas N, Michalopoulos NV, Agrogiannis G, Patsouris E, Korkolopoulou P. Levidou G, et al. World J Surg Oncol. 2012 Feb 29;10:47. doi: 10.1186/1477-7819-10-47. World J Surg Oncol. 2012. PMID: 22376079 Free PMC article. - Ultrasonic bioreactor as a platform for studying cellular response.
Subramanian A, Turner JA, Budhiraja G, Guha Thakurta S, Whitney NP, Nudurupati SS. Subramanian A, et al. Tissue Eng Part C Methods. 2013 Mar;19(3):244-55. doi: 10.1089/ten.TEC.2012.0199. Epub 2012 Sep 24. Tissue Eng Part C Methods. 2013. PMID: 22873765 Free PMC article. - The Influence of Reactive Oxygen Species in the Immune System and Pathogenesis of Multiple Sclerosis.
Tavassolifar MJ, Vodjgani M, Salehi Z, Izad M. Tavassolifar MJ, et al. Autoimmune Dis. 2020 Jun 25;2020:5793817. doi: 10.1155/2020/5793817. eCollection 2020. Autoimmune Dis. 2020. PMID: 32789026 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous